Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide
- 5 November 1984
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 77 (5), 59-61
- https://doi.org/10.1016/s0002-9343(84)80009-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide)American Journal Of Medicine, 1984
- Liquid Chromatographic Analysis of Triamterene and ItsMajor Metabolite, Hydroxytriamterene Sulfate, in Blood,Plasma, and UrineJournal of Pharmaceutical Sciences, 1984
- Preliminary observations on dissolution and bioavailability of triamterene–hydrochlorothiazide combination productsBiopharmaceutics & Drug Disposition, 1984
- Pharmacokinetics of triamterene and its metabolite in manJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Hydrochlorothiazide Pharmacokinetics and Pharmacologic Effect: The Influence of IndomethacinThe Journal of Clinical Pharmacology, 1982
- Pharmacokinetics of hydrochlorothiazide in manEuropean Journal of Clinical Pharmacology, 1977
- The influence of dosage form on the activity of a diuretic agentClinical Pharmacology & Therapeutics, 1968
- Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene‐hydrochlorothiazide combinationClinical Pharmacology & Therapeutics, 1967
- Potassium-Sparing Effects of Triamterene in the Treatment of HypertensionCirculation, 1966
- Triamterene with Hydrochlorothiazide in the Treatment of HypertensionJAMA, 1963